RH Bophelo (JSE:RHB) FFO


JSE:RHB RH Bophelo Ltd JSE:RHB
70 GF Score
Price R1.65
GF Value R6.13
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is RH Bophelo FFO?

FFO (Funds from operations) only applies to REITs.

JSE:RHB
70GF Score
RH Bophelo Ltd JSE:RHB
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is RH Bophelo (JSE:RHB) Overvalued in 2026?

Based on GuruFocus' analysis, RH Bophelo stock appears to be undervalued. The current stock price of R1.65 is trading 73.1% below its estimated GF Value™ of R6.13. GuruFocus considers RH Bophelo to be Possible Value Trap.

Key valuation signals for JSE:RHB:

  • FFO:
  • GF Value™: R6.13 vs. price of R1.65 (73.1% below fair value)
  • GF Score™: 70/100 with 4 warning signs

No single metric tells the full story. See the JSE:RHB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


RH Bophelo Business Description

Address 1, Melrose Boulevard, Unit 12, 1st Floor, Melrose Arch, Johannesburg, GT, ZAF, 2191
RH Bophelo Ltd is a healthcare investment company. Its main business involves the acquisition of healthcare assets in commercial entities or special situations across the South African market. It is engaged in making equity, quasi-equity, and equity-related investments in healthcare and financial sectors, specifically in operational infrastructure, health insurance, private hospital infrastructure, pharmaceuticals, retail and distribution, and healthcare technology. The company's operating segments are the Healthcare segment and the Financial Services segment. The majority of its revenue is generated from the Healthcare segment, which focuses on making investments in healthcare infrastructure, healthcare technology, and property companies.
70GF Score

Get the complete analysis for JSE:RHB

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R1.65
Price
R6.13
GF Value